Advertisement

Characterising non-melanoma skin cancer undergoing surgical management during the COVID-19 pandemic

  • Helen Capitelli-McMahon
    Correspondence
    Corresponding author at: Plastic & Reconstructive Surgery, Bradford Royal Infirmary, Duckworth Lane, Bradford BD9 6RJ, United Kingdom.
    Affiliations
    Department of Plastic and Reconstructive Surgery, Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Castle Road, Cottingham HU16 5JQ, England
    Search for articles by this author
  • Anna Hurley
    Affiliations
    Department of Plastic and Reconstructive Surgery, Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Castle Road, Cottingham HU16 5JQ, England
    Search for articles by this author
  • Richard Pinder
    Affiliations
    Department of Plastic and Reconstructive Surgery, Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Castle Road, Cottingham HU16 5JQ, England
    Search for articles by this author
  • Paolo Matteucci
    Affiliations
    Department of Plastic and Reconstructive Surgery, Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Castle Road, Cottingham HU16 5JQ, England
    Search for articles by this author
  • Joshua Totty
    Affiliations
    Department of Plastic and Reconstructive Surgery, Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Castle Road, Cottingham HU16 5JQ, England
    Search for articles by this author
Published:October 31, 2020DOI:https://doi.org/10.1016/j.bjps.2020.10.042
      Throughout the COVID-19 pandemic, plastic surgery departments have strived to keep oncological services running despite significant operational pressures. Access to healthcare generally declined in all but the most urgent circumstances, and departments have already identified a reduction in referrals and diagnoses of skin malignancies.
      • Earnshaw C.H.
      • Hunter H.J.A.
      • McMullen E.
      • Griffiths C.E.M.
      • Warren R.B.
      Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Earnshaw C.H.
        • Hunter H.J.A.
        • McMullen E.
        • Griffiths C.E.M.
        • Warren R.B.
        Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic.
        Br J Dermatol. 2020; 183: 792-794
        • Rosenbaum L.
        The untold toll — the pandemic's effects on patients without Covid-19.
        New England J Med. 2020; 382: 2368-2371
        • Nolan G.S.
        • Wormald J.C.R.
        • Kiely A.L.
        • Totty J.P.
        • Jain A.
        Global incidence of incomplete surgical excision in adult patients with non-melanoma skin cancer: study protocol for a systematic review and meta-analysis of observational studies.
        Syst Rev. 2020; 9: 83
        • Ranjan R.
        • Singh L.
        • Arava S.K.
        • Singh M.K.
        Margins in skin excision biopsies: principles and guidelines.
        Indian J Dermatol. 2014; 59: 567-570